Related Experiment Video
Updated: Jul 5, 2025

09:30
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
3.1K
Analysis of Xp22.31q27.1 Region Variation Detection based on SNP Array Technology.
Clinical Laboratory
|January 12, 2024
Summary
Single nucleotide polymorphism array (SNP array) technology effectively detects fetal chromosomal microdeletions and microduplications missed by traditional methods. This advanced SNP array analysis offers a valuable supplementary tool for prenatal diagnosis.
Area of Science:
- Genetics
- Prenatal Diagnostics
- Molecular Biology
Background:
- Traditional chromosome karyotype analysis has limitations in detecting subtle genetic variations.
- The Xp22.31q27.1 region is a critical area for genetic variations.
- Advancements in molecular technologies are crucial for improving prenatal diagnostic accuracy.
Purpose of the Study:
- To evaluate the diagnostic utility of single nucleotide polymorphism array (SNP array) technology in prenatal diagnosis.
- To compare the detection capabilities of SNP array technology versus chromosome karyotype analysis.
- To identify chromosomal abnormalities in the Xp22.31q27.1 region using SNP array technology.
Main Methods:
- SNP array technology was employed to analyze variants in the Xp22.31q27.1 region of 13 fetuses.
- Chromosome karyotype analysis was performed on the fetuses and their parents for comparative assessment.
- Analysis included identifying gene content (OMIM genes) and inheritance patterns (maternal, paternal, de novo).
Main Results:
- Chromosome karyotype analysis revealed no obvious abnormalities at 400-band resolution.
- SNP array technology identified mutations in the Xp22.31q27.1 region in all 13 fetuses.
- The majority of mutations were Xp22.31 lesions (61.5%), involving 2-5 OMIM genes, with both deletions and duplications detected. Inheritance patterns included maternal, paternal, and de novo variants.
Conclusions:
- SNP array technology significantly enhances the detection of chromosomal microdeletions and microduplications compared to traditional karyotyping.
- SNP array technology serves as a powerful supplementary diagnostic method in clinical cytogenetics.
- This technology improves the accuracy and comprehensiveness of prenatal genetic screening.
More Related Videos
Related Concept Videos
Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K

